glp-1 receptor agonists weight loss Top Balance Efficacy, Safety Frontiers | GLP-1 Receptor Agonists:
Description
Hansen HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, Schlumberger C, Jelsing J, et al
Accordingly, GLP-1RAs have been increasingly used in the treatment of PCOS because of their ability to reduce weight and improve IR (155159)
These agents mimic the action of endogenous GLP-1, an incretin hormone released from intestinal L-cells in response to nutrient intake
55 Indeed, a more recent large meta-analysis confirmed that while GIPR variants may influence BMD, this does not necessarily translate to increased bone fracture risk
